Exocrine Pancreatic Insufficiency Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
Exocrine Pancreatic Insufficiency (EPI) is a type of medical condition where the pancreas are not able to produce sufficient digestive enzymes, leading to malabsorption of nutrients and malnutrition. EPI can be caused by various factors, including chronic pancreatitis, pancreatic cancer, and cystic fibrosis. EPI is commonly treated with enzyme replacement therapy (ERT), which replaces the missing digestive enzymes with oral supplements. ERT is an effective way to improve nutrient absorption and alleviate symptoms, making it a valuable treatment option for people with EPI. The end-users of EPI treatments are typically individuals who have been diagnosed with EPI, as well as healthcare providers who prescribe these treatments. ERT is an important tool for preventing malnutrition and enhancing quality of life for people with EPI. The future of the EPI market looks promising, driven by the growing recognition of the benefits of ERT, and advancements in treatment options.
MARKET SCOPE
The "Global Exocrine Analysis To 2031" is a specialized and in-depth study of the medical device industry with a focus on the exocrine trend. The report aims to provide an overview of global exocrine with detailed market segmentation by type, end user and geography. The global exocrine is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the exocrine.
MARKET SEGMENTATION
The global anesthesia machines market is segmented on the basis of product and end user. The product segment includes stand-alone anesthesia machines and portable anesthesia machines. Based on end user, the exocrine pancreatic insufficiency market is classified as, hospitals, clinics, and ambulatory surgical centers.
MARKET DYNAMICS
The exocrine pancreatic insufficiency market is likely to anticipate grow with a significant rate in the forecast years, owing to driving factors such as, rise in the prevalence of gastrointestinal disorders, ulcerative colitis, and small intestinal bacterial growth among others. In addition, increasing prevalence of the cystic fibrosis, pancreatic cancer, diabetes are likely to grow the market in the forecast years. The market is likely to seek various opportunities to develop easy test and innovative products to treat the exocrine pancreatic insufficiency.
REGIONAL FRAMEWORK
The global exocrine pancreatic insufficiency market is segmented on the basis of type and end user. On the basis type segment includes imaging and sample test. The imaging segment is further divided into sub-segments such as CT scanning, endoscopic ultra-sonography (EUS), magnetic resonance imaging (MRI) and others. Similarly, the sample test is further divided into blood test, fecal test and pancreatic function test. On the basis of the end user the segment is classified as hospitals, diagnostic laboratories, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global exocrine pancreatic insufficiency market based on type, end user and geography. It also provides market size and forecast till 2031 for overall exocrine pancreatic insufficiency market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the exocrine pancreatic insufficiency market in the coming years, owing to factors such as, rise in the incidences of the bacterial infection, rise in the prevalence of the exocrine pancreatic insufficiency and more. The Europe and Asia Pacific market is anticipated to hold large market share following the North America. The rise in the geriatric population across these regions are likely to contribute to the significant growth rate for the market.
Mrinal Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. 
Have a question?
Speak to Analyst
The global exocrine pancreatic insufficiency market is segmented on the basis of type and end user. On the basis type segment includes imaging and sample test. The imaging segment is further divided into sub-segments such as CT scanning, endoscopic ultra-sonography (EUS), magnetic resonance imaging (MRI) and others. Similarly, the sample test is further divided into blood test, fecal test and pancreatic function test. On the basis of the end user the segment is classified as hospitals, diagnostic laboratories, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global exocrine pancreatic insufficiency market based on type, end user and geography. It also provides market size and forecast till 2031 for overall exocrine pancreatic insufficiency market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the exocrine pancreatic insufficiency market in the coming years, owing to factors such as, rise in the incidences of the bacterial infection, rise in the prevalence of the exocrine pancreatic insufficiency and more. The Europe and Asia Pacific market is anticipated to hold large market share following the North America. The rise in the geriatric population across these regions are likely to contribute to the significant growth rate for the market.
MARKET PLAYERS
The report also includes the profiles of key exocrine pancreatic insufficiency market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medtronic, General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, Canon Medical Systems, USA, ThermoFisher Scientific Inc., ScheBo Biotech AG, Hologic Inc., Immunostics, Inc. and Biohit Oyj.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Table of Contents
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. EXOCRINE PANCREATIC INSUFFICIENCY MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Exocrine Pancreatic Insufficiency Market - By Type
3.2.2. Exocrine Pancreatic Insufficiency Market - By End User
3.2.3. Exocrine Pancreatic Insufficiency Market - By Region
3.2.3.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. EXOCRINE PANCREATIC INSUFFICIENCY MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2028 - BY TYPE
5.1. OVERVIEW
5.2. TYPE MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
5.3. IMAGING MARKET
5.3.1. Overview
5.3.2. Imaging Market Revenue Forecasts and Analysis (US$ Mn)
5.3.3. Computerized Tomography Scan Market
5.3.3.1. Overview
5.3.3.2. Computerized Tomography Scan Market Revenue Forecasts and Analysis (US$ Mn)
5.3.4. Magnetic Resonance Imaging Market
5.3.4.1. Overview
5.3.4.2. Magnetic Resonance Imaging Market Revenue Forecasts and Analysis (US$ Mn)
5.3.5. Endoscopic Ultrasonography Market
5.3.5.1. Overview
5.3.5.2. Endoscopic Ultrasonography Market Revenue Forecasts and Analysis (US$ Mn)
5.3.6. Others Market
5.3.6.1. Overview
5.3.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
5.4. SAMPLE TEST MARKET
5.4.1. Overview
5.4.2. Sample Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.3. Blood Test Market
5.4.3.1. Overview
5.4.3.2. Blood Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.4. Faecal Test Market
5.4.4.1. Overview
5.4.4.2. Faecal Test Market Revenue Forecasts and Analysis (US$ Mn)
5.4.5. Pancreatic Function Test Market
5.4.5.1. Overview
5.4.5.2. Pancreatic Function Test Market Revenue Forecasts and Analysis (US$ Mn)
6. EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2028 - BY END USER
6.1. OVERVIEW
6.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. HOSPITALS MARKET
6.3.1. Overview
6.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
6.4. DIAGNOSTIC LABORATORIES MARKET
6.4.1. Overview
6.4.2. Diagnostic Laboratories Market Revenue Forecasts and Analysis (US$ Mn)
6.5. OTHERS MARKET
6.5.1. Overview
6.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
7. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
7.1. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
7.2. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
7.3. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
7.3.1. North America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.3.2. North America Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.4. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
7.5. NORTH AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
7.6. US MARKET OVERVIEW
7.6.1. US Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.6.1.1. US Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.6.1.2. US Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.6.2. US Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
7.7. CANADA MARKET OVERVIEW
7.7.1. Canada Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.7.1.1. Canada Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.7.1.2. Canada Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.7.2. Canada Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
7.8. MEXICO MARKET OVERVIEW
7.8.1. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
7.8.1.1. Mexico Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.8.1.2. Mexico Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
7.8.2. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Application (US$ Mn)
7.8.3. Mexico Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
8.1. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
8.2. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
8.3.1. Europe Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.3.2. Europe Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.4. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
8.5. EUROPE EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
8.6. UK MARKET OVERVIEW
8.6.1. UK Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.6.1.1. UK Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.1.2. UK Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.6.2. UK Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.7. GERMANY MARKET OVERVIEW
8.7.1. Germany Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.7.1.1. Germany Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.1.2. Germany Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.7.2. Germany Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
8.8. FRANCE MARKET OVERVIEW
8.8.1. France Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
8.8.1.1. France Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.1.2. France Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
8.8.2. France Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
9.1. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
9.2. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
9.3.1. Asia Pacific Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.3.2. Asia Pacific Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.5. ASIA PACIFIC EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.6. CHINA MARKET OVERVIEW
9.6.1. China Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.6.1.1. China Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.1.2. China Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.6.2. China Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.7. JAPAN MARKET OVERVIEW
9.7.1. Japan Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.7.1.1. Japan Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.1.2. Japan Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2. Japan Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. INDIA MARKET OVERVIEW
9.8.1. India Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
9.8.1.1. India Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.1.2. India Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2. India Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
10.1. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
10.2. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
10.3.1. Middle East and Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.3.2. Middle East and Africa Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.5. MIDDLE EAST AND AFRICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.6. UAE MARKET OVERVIEW
10.6.1. UAE Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.6.1.1. UAE Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.1.2. UAE Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.6.2. UAE Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.7. SAUDI ARABIA MARKET OVERVIEW
10.7.1. Saudi Arabia Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.7.1.1. Saudi Arabia Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.1.2. Saudi Arabia Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.2. Saudi Arabia Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. SOUTH AFRICA MARKET OVERVIEW
10.8.1. South Africa Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
10.8.1.1. South Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.1.2. South Africa Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2. South Africa Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS TO 2028 - COUNTRY ANALYSIS
11.1. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET OVERVIEW
11.2. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY TYPE (US$ MN)
11.3.1. South and Central America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.3.2. South and Central America Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.4. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. SOUTH AND CENTRAL AMERICA EXOCRINE PANCREATIC INSUFFICIENCY MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. BRAZIL MARKET OVERVIEW
11.6.1. Brazil Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By Type (US$ Mn)
11.6.1.1. Brazil Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.1.2. Brazil Sample Test Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2. Brazil Exocrine Pancreatic Insufficiency Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. INDUSTRY LANDSCAPE
12.1. ORGANIC GROWTH STRATEGIES
12.1.1. New Product Launches
12.1.2. Marketing & Promotional Activities
12.2. INORGANIC GROWTH STRATEGIES
12.2.1. Partnerships, Collaborations, and Joint Ventures
12.2.2. Mergers & Acquisitions
13. EXOCRINE PANCREATIC INSUFFICIENCY MARKET, KEY COMPANY PROFILES
13.1. MEDTRONIC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GENERAL ELECTRIC COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. KONINKLIJKE PHILIPS N.V.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Type/Type Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SIEMENS HEALTHCARE GMBH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CANON MEDICAL SYSTEMS, USA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. THERMOFISHER SCIENTIFIC INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SCHEBO BIOTECH AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. HOLOGIC INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. IMMUNOSTICS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BIOHIT OYJ
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
The List of Companies
1. Medtronic
2. General Electric Company
3. Koninklijke Philips N.V.
4. Siemens Healthcare GmbH
5. Canon Medical Systems, USA
6. ThermoFisher Scientific Inc.
7. ScheBo Biotech AG
8. Hologic Inc.
9. Immunostics, Inc.
10. Biohit Oyj
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For